Xavier Delavenne (X Delavenne)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Venous Thromboembolism

Direct Oral Anticoagulants

Top Venues

British journal of clinical pharmacology

Haemophilia : the official journal of the World Federation of Hemophilia

Journal of functional biomaterials

Thrombosis and haemostasis

This page only lists publications with an associated author ORCID identifier.

Publications

Benoit Guillet, Maxime Pawlowski, Pierre Boisseau, Yohann Repesse, Philippe Beurrier, Sophie Bayart, Xavier Delavenne, Marc Trossaërt, Peter J Lenting
Genotype-dependent response to desmopressin in hemophilia A and proposal of a predictive response score. Thrombosis and haemostasis (2024)
Florine Grossetete, Charlotte Garot, Emmanuel Crouzet, Xavier Delavenne, Philippe Gain, Laurence Barnouin, Gilles Thuret
In Vitro/Ex Vivo Release Study of a Ground Umbilical Cord Matrix Loaded with Dexamethasone. Journal of functional biomaterials 15 (6) (2024)
Benoît Guillet, Maxime Pawlowski, Pierre Boisseau, Yohann Répessé, Philippe Beurrier, Sophie Bayart, Xavier Delavenne, Marc Trossaërt, Peter J Lenting
Genotype-Dependent Response to Desmopressin in Hemophilia A and Proposal of a Predictive Response Score. Thrombosis and haemostasis (2024)
Florine Grossetete, Charlotte Garot, Emmanuel Crouzet, Xavier Delavenne, Philippe Gain, Laurence Barnouin, Gilles Thuret
In Vitro/Ex Vivo Release Study of a Ground Umbilical Cord Matrix Loaded with Dexamethasone. Journal of functional biomaterials 15 (6) (2024)
Florine Grossetete, Charlotte Garot, Emmanuel Crouzet, Xavier Delavenne, Philippe Gain, Laurence Barnouin, Gilles Thuret
In Vitro/Ex Vivo Release Study of a Ground Umbilical Cord Matrix Loaded with Dexamethasone. Journal of functional biomaterials 15 (6) (2024)
Stéphanie Désage, Alexandre Leuci, Nathalie Enjolras, Lori A Holle, Sneha Singh, Xavier Delavenne, Alisa S Wolberg, Arijit Biswas, Dargaud Yesim
Characterization of a recombinant factor IX molecule fused to coagulation factor XIII-B subunit. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Benoit Guillet, Abel Hassoun, Bénédicte Wibaut, Annie Harroche, Christine Biron-Andréani, Yohan Repesse, Roseline d'Oiron, Brigitte Tardy, Brigitte Pan Petesch, Pierre Chamouni, Valérie Gay, Marc Fouassier, Claire Pouplard, Cédric Martin, Hasan Catovic, Xavier Delavenne
A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis. Thrombosis and haemostasis (2023)
Lara Leclerc, Nathalie Prévôt, Sophie Hodin, Xavier Delavenne, Heribert Mentzel, Uwe Schuschnig, Jérémie Pourchez
Acoustic Aerosol Delivery: Assessing of Various Nasal Delivery Techniques and Medical Devices on Intrasinus Drug Deposition. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Brigitte Tardy, Thierry Lambert, Pierre Chamouni, Aurélie Montmartin, Marc Trossaërt, Ségolène Claeyssens, Claire Berger, Laurent Ardillon, Valérie Gay, Xavier Delavenne, Annie Harroche, Pierre Chelle
Revised terminal half-life of nonacog alfa as derived from extended sampling data: A real-world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis. Haemophilia : the official journal of the World Federation of Hemophilia 28 (4) (2022)
Audrick Gibert, Julien Lanoiselée, Luc Janisset, Gilles Pernod, Edouard Ollier, Xavier Delavenne
Development of a Bayesian estimation tool to determine the optimal duration of apixaban discontinuation before a high-bleeding risk procedure. Fundamental & clinical pharmacology 36 (5) (2022)
Sonia Saïb, Xavier Delavenne
Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition. Pharmaceutics 13 (10) (2021)
Laurent Bertoletti, Xavier Jaïs, Souad Bezzeghoud, Xavier Delavenne
Direct oral anticoagulants: Still too early for prime time after pulmonary endarteriectomy? Journal of thrombosis and haemostasis : JTH 18 (3) (2020)
Xavier Delavenne, Edouard Ollier, Anne Lienhart, Dargaud Yesim
A new paradigm for personalized prophylaxis for patients with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 26 (2) (2020)
Guillaume Claisse, Paul J Zufferey, Jane C Trone, Nicolas Maillard, Xavier Delavenne, Silvy Laporte, Edouard Ollier
Predicting the dose of vancomycin in ICU patients receiving different types of RRT therapy: a model-based meta-analytic approach. British journal of clinical pharmacology 85 (6) (2019)
Xavier Delavenne, Yesim Dargaud, Edouard Ollier, Claude Négrier
Dose tailoring of human cell line-derived recombinant factor VIII simoctocog alfa: Using a limited sampling strategy in patients with severe haemophilia A. British journal of clinical pharmacology 85 (4) (2019)
Virginie Siguret, Johan Abdoul, Xavier Delavenne, Emmanuel Curis, Audrey Carlo, Anne Blanchard, Joe-Elie Salem, Pascale Gaussem, Christian Funck-Brentano, Michel Azizi, Patrick Mismetti, Marie-Anne Loriot, Thomas Lecompte, Isabelle Gouin-Thibault
Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variability. Journal of thrombosis and haemostasis : JTH 17 (10) (2019)
Paul J Zufferey, Edouard Ollier, Xavier Delavenne, S Laporte, P Mismetti, S B Duffull
Incidence and risk factors of major bleeding following major orthopaedic surgery with fondaparinux thromboprophylaxis. A time-to-event analysis. British journal of clinical pharmacology 84 (10) (2018)
Dargaud Yesim, Xavier Delavenne, D P Hart, S Meunier, P Mismetti
Individualized PK-based prophylaxis in severe haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia (2018)
Sophie Hodin, Thierry Basset, Elodie Jacqueroux, Olivier Delezay, Anthony Clotagatide, Nathalie Perek, Patrick Mismetti, Xavier Delavenne
In Vitro Comparison of the Role of P-Glycoprotein and Breast Cancer Resistance Protein on Direct Oral Anticoagulants Disposition. European journal of drug metabolism and pharmacokinetics 43 (2) (2018)
Julien Lanoiselée, Paul J Zufferey, Edouard Ollier, Sophie Hodin, Xavier Delavenne, null null
Is tranexamic acid exposure related to blood loss in hip arthroplasty? A pharmacokinetic-pharmacodynamic study. British journal of clinical pharmacology 84 (2) (2017)